文献速递颈动脉与弓上血管

无症状非八旬患者颈动脉狭窄支架与内膜剥脱术对比

Treatment of carotid stenosis in asymptomatic, nonoctogenarian, standard risk patients with stenting versus endarterectomy trials.
PubMed 文献 · J Vasc Surg · 2021-10-22

汇总两项随机试验的2544例≥70%无症状颈动脉狭窄、年龄小于80岁患者数据,比较经股动脉栓塞保护下颈动脉支架术(CAS)与颈动脉内膜剥脱术(CEA)的结局。围手术期及4年内主要复合终点CAS与CEA无显著差异(5.3% vs 5.1%;HR 1.02;95%CI 0.7-1.5;

要点

  • 无症状非八旬标准风险患者中,CAS与CEA的主要复合终点无显著差异。

核心结论

  • 在无症状、非八旬患者中,CAS与CEA的短期和长期结果相当。

研究设计与样本

  • 对两项大型随机试验的患者水平数据汇总分析,共2544例≥70%无症状颈动脉狭窄且年龄小于80岁的患者随机接受CAS或CEA并联合标准药物治疗。
  • 一项试验纳入1091例(CAS 548例,CEA 543例),另一项纳入1453例(CAS 1089例,CEA 364例)。
  • 进行独立神经学评估和常规心肌酶筛查,预设主要复合终点为围手术期任何卒中、心肌梗死或死亡及随机化后4年内同侧卒中。

临床怎么用

  • 对于无症状、非八旬、标准风险且狭窄≥70%的患者,CAS可作为与CEA相当的再血管化选择。
  • 决策时需结合围手术期风险构成:CAS卒中数值偏高而CEA心肌梗死较高。
  • 术后4年内需持续监测同侧卒中风险,两组均约2%余。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Asymptomatic carotid stenosis is the most frequent indication for carotid endarterectomy (CEA) in the United States. Published trials and guidelines support CEA indications in selected patients with longer projected survival and when periprocedural complications are low. Transfemoral carotid artery stenting with embolic protection (CAS) is a newer treatment option. The objective of this study was to compare outcomes in asymptomatic, nonoctogenarian patients treated with CAS vs CEA. METHODS: Patient-level data was analyzed from 2544 subjects with ≥70% asymptomatic carotid stenosis who were randomized to CAS or CEA in addition to standard medical therapy. One trial enrolled 1091 (548 CAS, 543 CEA) and another enrolled 1453 (1089 CAS, 364 CEA) asymptomatic patients less than 80 years old (upper age eligibility). Independent neurologic assessment and routine cardiac enzyme screening were performed. The prespecified, primary composite endpoint was any stroke, myocardial infarction, or death during the periprocedural period or ipsilateral stroke within 4 years after randomization. RESULTS: There was no significant difference in the primary endpoint between CAS and CEA (5.3% vs 5.1%; hazard ratio, 1.02; 95% confidence interval, 0.7-1.5; P = .91). Periprocedural rates for the components are (CAS vs CEA): any stroke (2.7% vs 1.5%; P = .07), myocardial infarction (0.6% vs 1.7%; P = .01), death (0.1% vs 0.2%; P = .62), and any stroke or death (2.7% vs 1.6%; P = .07). After this period, the rates of ipsilateral stroke were similar (2.3% vs 2.2%; P = .97). CONCLUSIONS: In a pooled analysis of two large randomized trials of CAS and CEA in asymptomatic, nonoctogenarian patients, CAS achieves comparable short- and long-term results to CEA.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Matsumura JS, Hanlon BM, Rosenfield K, et al. Treatment of carotid stenosis in asymptomatic, nonoctogenarian, standard risk patients with stenting versus endarterectomy trials. J Vasc Surg. 2021. PMID: 34695552. doi:10.1016/j.jvs.2021.10.020

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。